Riskpilot← Back to searchSign inGet full accessPERASPERA AS
ASActiveOrg 919176393Olav Hegnas vei 5A, 0585 OsloMedical specialists activities · NACE 8622Est. 20171 employees
Revenue 2025
NOK 37K
-41% vs 2024
EBITDA margin
-17.8%
-138% vs 2024
Equity ratio
66.9%
Financial strength
Net profit 2025
NOK -7K
-138% vs 2024
| Revenue | NOK 37K | -41% |
| EBITDA | NOK -7K | -138% |
| Net profit | NOK -7K | -138% |
| Total assets | NOK 249K | -7% |
| Equity | NOK 167K | -4% |
| Employees | 1 | — |
Legal name
PERASPERA AS
Org number
919176393
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
21. juni 2017
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Medisinsk tjeneste i form av konsulent og rådgivningstjeneste innen spesialisthelsetjeneste samt formidling og utleie av spesialister innen ulike helsesektorer. Utvikling og utleie av eiendom generell, men med fokus på medisinsk bruk. Investere i aksjer og andre verdipapirer.
Address
Olav Hegnas vei 5A, 0585 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 171 | 209 | 144 | 63 | 37 |
| Staff expenses | −15 | −49 | −39 | −12 | −6 |
| EBITDA | 88 | 64 | −46 | 17 | −7 |
| Depreciation & amort. | −11 | −23 | −14 | −0 | −0 |
| EBIT | 77 | 40 | −59 | 17 | −7 |
| Net financials | 0 | −0 | 1 | 0 | 0 |
| Profit before tax | 77 | 40 | −59 | 18 | −7 |
| Tax | 18 | 10 | 2 | 0 | −0 |
| Net profit | 59 | 31 | −61 | 17 | −7 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 293 | 313 | 248 | 267 | 249 |
| Equity | 187 | 217 | 156 | 173 | 167 |
| Long-term debt | −40 | 0 | 0 | 0 | 0 |
| Short-term debt | 146 | 96 | 92 | 94 | 83 |
| Total debt | 106 | 96 | 92 | 94 | 83 |
EBITDA margin
-17.8%
This company
15.8%
Market median
-213% vs market
20212025
Equity ratio
66.9%
This company
38.2%
Market median
+75% vs market
20212025
Return on equity
-3.9%
This company
18.4%
Market median
-121% vs market
20212025
Net profit margin
-17.8%
This company
8.1%
Market median
-320% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS Deputy Member | Deputy Member | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PERASPERA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katrin Schauer | Deputy Member | 0 companies |
| Stefan Huhnstock | Chairman | 0 companies |